General Hospital Psychiatry
Volume 26, Issue 3 , Pages 242-243 , May 2004

A case of social phobia with obsessive-compulsive symptoms improved by paroxetine in combination with risperidone

References 

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994;
  2. Brunello N, den Boer JA, Judd LL, et al.  Social phobia (diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment). J Affect Disord. 2000;60:61–74
  3. McDougle CJ. Update on pharmacologic management of OCD (agents and augmentation). J Clin Psychiatry. 1997;58(Suppl. 12):11–17
  4. Dick CL, Sowa B, Bland RC, et al.  Epidemiology of psychiatric disorders in Edmonton. Phobic disorders. Acta Psychiatr Scand Suppl. 1994;376:36–44
  5. Rasmussen SA, Tsuang MT. Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry. 1986;143:317–322
  6. Mikkelsen EJ, Detlor J, Cohen DJ. School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder. Am J Psychiatry. 1981;138:1572–1576
  7. Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology. 2003;60:1130–1135

☆ Ken Yamauchi, Department of Psychiatry, University of Tokushima School of Medicine 3-8-15 Kuramoto-cho Tokushima 770-8503, Japan

PII: S0163-8343(04)00010-6

doi: 10.1016/j.genhosppsych.2003.12.002

General Hospital Psychiatry
Volume 26, Issue 3 , Pages 242-243 , May 2004

Article Tools